Maureen Dubreuil MD

Rheumatologist at Boston University Medical Center and VA Boston Health Care System

725 Albany StRheumatology Suite 7bBoston, MA 02118
Phone+1 617-638-7460

Dr. Dubreuil is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dubreuil's full profile Already have an account?

Education & Training

Boston University Medical CenterFellowship, Rheumatology, 2010 - 2012
Boston University Medical CenterResidency, Internal Medicine, 2006 - 2009
Uconn School Of MedicineClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2009 - 2028
American Board of Internal Medicine Rheumatology

Publications & Presentations

PubMed

Effect of Bimekizumab Treatment on Health Status, Work Productivity, and Productivity Costs Through 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.
Elena Nikiphorou, William Tillett, Atul Deodhar, Maureen Dubreuil, Laure Gossec
The Journal of Rheumatology. 2026-08-07
Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBI...
Victoria Navarro-Compán, Uta Kiltz, Philip J Mease, Maureen Dubreuil, Karl Gaffney
RMD Open. 2026-05-13
1 citations
Effect of Early Tumor Necrosis Factor Inhibitor Initiation on Chronic Opioid Use in Individuals With Axial Spondyloarthritis.
Eva Petrow, Jose A Meade-Aguilar, Christine Peloquin, S Reza Jafarzadeh, Tuhina Neogi
Arthritis Care & Research. 2026-01-01

Press Mentions

TNF Inhibitors May Reduce Fracture Risk 29% vs NSAIDs in Axial SpondyloarthritisFebruary 20th, 2025
You Can Tell SpA Patients That TNF Inhibitors May Cut Fracture RiskDecember 16th, 2024
How Medicine Erased Black Women from a ‘White Man’s Disease’December 21st, 2021